NATHANIEL ROBB WHALEY MD

Transcription

1 NATHANIEL ROBB WHALEY MD Tri-State Mountain Neurology Associates 1321 Sunset Drive, Suite 11 Johnson City, TN hone: ( 608) EDUCATION Medical: Undergraduate: M.D., East Tennessee State Univ rsity, James H. Quillen College of Medicine, Johnson Ci, TN B.S. in Chemistry, East Tenness e State University College of Arts and Sciences, Johnson Ci y, TN POSTGRADUATE TRAINING Fellowship: PGY II-IV: Fellowship: Internship: Neurophysiology, Mayo Clinic, acksonville, FL Neurology, Mayo Clinic, Jacks]ville, FL Research Fellow in Movement disorders, Smith Fellowship in Neuroiogic Disease, Mayo Cli ic, Jacksonville, FL Internal Medicine, Mayo Clinic, Saint Luke's Hospital, Jacksonville, FL MEDICAL LICENSURE Li censure: State of Tennessee License Number: ME CERTIFICATION Present American Board of Psychiatry a d Neurology PROFESSIONAL EXPERIENCE Present Neurologist, Tri-State Mountai Neurology Associates, Johnson City, TN 8/23/2018 1

2 PROFESSIONAL MEMBERSHIPS AWARDS AND RECOGNITION Tennessee Medical Association, 2015 Present American Academy of Neurology, 2005 Present 1997 Graduated Magna Cum Laude, East Tennessee State University, College of Arts and Sciences 1996 Organic Chemistry Research Fellowship, University of Tennessee, Knoxville, TN Chemistry Endowed Scholarship Award, Chemistry Department, East Tennessee State University, Johnson City, TN TEACHING ACTIVITIES Present Associate Professor, Neurology, East Tennessee State University College of Medicine, Johnson City, TN LECTURES/SPEECHES To Be a Neurologist: Lunch and Learn Conference. Quillen College of Medicine. January 23, Peripheral Neuropathy: Resident Noon Conference. Mountain Home Veterans Administration, Johnson City, TN. December 7, Movement Disorders 101: Resident Noon Conference Mountain Home Veterans Administration, Johnson City, TN. September Subdural Epidural Lipomatosis A rare cause of lumbar spinal stenosis. Clinical Neurophysiology Conference, Mayo Clinic, Florida. June 12, Electrodiagnostic Findings in Conus Medullaris Infarction. Clinical Neurophysiology Conference (teleconference to Mayo Rochester), Mayo Clinic, Florida. May 29, Focal Myopathy in Myasthenia Gravis. Clinical Neurophysiology Conference (teleconference to Mayo Rochester). March 27, Interesting Case: Deep ulnar motor branch palsy. Mayo Clinic Neurophysiology Course, Amelia Island, FL. March 11, Laryngeal Myotonia in Paramyotonia Congenita. Clinical Neurophysiology Conference (teleconference to Mayo Rochester), Mayo Clinic, Florida. January 30, Correlation between Achilles reflex electrically-induced soleus H-reflex and mechanicallyinduced H-reflex in S1 radiculopathy. Clinical Neurophysiology Conference, Mayo Clinic, Florida. December 11, Case Presentation: Almost ALS. Clinical Neurophysiology Conference, Mayo Clinic, Florida. November 21, Case Presentation: A Twist at the Wrist and a Wasted Hand. Clinical Neurophysiology Conference, Mayo Clinic, Florida. October 10, Case Presentation: Left anterior interosseous neuropathy in recurrent brachial plexitis. Clinical Neurophysiology Conference, Mayo Clinic, Florida. August 15, /23/2018 2

3 A Case of Progressive MS. 3 rd Annual MASTER Multiple Sclerosis Fellowship. Fort Lauderdale, FL. November 11, Essential Tremor: Phenotype in a Clinical Cohort. Florida Society of Neurology Meeting. Orlando, FL. September 29, Inherited Ataxias. Nemours Pediatric Case Conference, Jacksonville, FL. June 22, Case Presentation: A Christmas case of encephalopathy: acute renal failure and gadolinium lights in the subarachnoid space. Neurocritical Care Conference. Mayo Clinic, Florida. December 28, Case Conference: Spinal Epidural Lipomatosis. Clinical Neurophysiology Conference. Mayo Clinic, Jacksonville, FL. November 16, Stoke: Pathophysiology and Mechanism. Neuro Education Lecture Presentation to Nursing staff of St. Luke s Hospital. August 23, Stroke: Pathophysiology and Mechanism. Neuro Education Lecture Presentation to Nursing staff of St. Luke s Hospital. June 28, Inherited Ataxia: General Overview. Lecture to the International Ataxia Support Group of Jacksonville. June 24, Mayo Clinic Jacksonville Intensive Care Case Conference. October 7, Mayo Clinic Jacksonville Intensive Care Morbidity and Mortality Conference. Case Presentation. December 22, Whaley, NR, Putzke JD, Wszolek ZK, Wharen RE, Uitti RJ. Unilateral deep brain stimulation in the subthalamic nucleaus for advanced Parkinson s disease (9 th International Congress of Parkinson s Disease and Movement Disorders, New Orleans, LA, 2005). Movement Disorders 2005;20 (Suppl 10):S151. Whaley NR, Putzke JD, Baba Y, Wszolek ZK, Uitti RJ. Defining the essential tremor phenotype: initial symptoms and baseline characteristics in a clinical cohort (18 th Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson s Disease and other Movement Disorders, Toronto, Canada, 2004). Mov Disord. 2004;19:1134. GRANDS ROUNDS February 11, 2008 Transferritin Familial Amyloidosis. Neurology Grand Rounds, Mayo Clinic, Florida. January 19, 2007 Case Presentation: Embolic stroke 2 nd to cardioembolism in a man with atrial fibrillation 2 nd to hyperthyroidism. Professor Rounds (Benjamin Eidelman, M.D.), Mayo Clinic, Florida. December 8, 2006 Case Presentation: Acute onset of dysarthria and triplegia. Professor Rounds (Benjamin Eidelman, M.D.). Mayo Clinic, Florida. October 30, 2006 Case Presentation: Spinal Epidural Lipomatosis. Neurology Grand Rounds. Kinne Auditorium, Mayo Clinic, Jacksonville, Florida. ABSTRACTS Whaley NR, Kennelly K, Dimberg E. Laryngeal myotonia in paramyotonia congentia. American Association of Neuromuscular and Electrodiagnostic Medicine Annual Meeting. San Diego, California. October 7-10, /23/2018 3

4 Whaley N, Putzke J, Uitti RJ, Baba Y, Wszolek ZK. Phenotype comparison of familial and sporadic essential tremor. Parinsonism & Related Disorder 2005;11 (Suppl 2): Uitti RJ, Baba Y, Markopoulou K, Putzke JD, Whaley NR, Imamura A, Farrer MJ, Wszolek ZK. Comparison of clinical phenotype between familial and sporadic Parkinson s disease. Neurology 2005;64 (Suppl 1):A Whaley, NR, Putzke JD, Wszolek ZK, Wharen RE, Uitti RJ. Unilateral deep brain stimulation in the subthalmic nucleus for advanced Parkinson s disease. Movement Disorders 2005;20 (Suppl 10):S151. Putzke JD, Whaley NR, Baba Y, Uitti RJ, Wszolek ZK. Essential tremor: long-term follow-up of a clinical cohort. Neurology 2005,64 (Suppl 1):A254. Whaley NR, Putzke JD, Baba Y, Wszolek ZK, Uitti RJ. Defining the essential tremor phenotype: Initial symptoms and baseline characteristics in a clinical cohort. Movement Disorders 2004;19 (Suppl 9): PUBLICATONS Fujioka S, Sanchez Contreras MY, Stongosky AJ, Ogaki K, Whaley NR, Tacik PM, van Gerpen JA, Uitti RJ, Ross OA, Wszolek ZK, Rademakers R, Dickson DW. Three sib-pairs of autopsyconfirmed progressive supranuclear palsy. Parkinsonism Relat Disord 2015 Feb:21(2): Nathaniel Robb Whaley, Shinsuke Fujioka, and Zbigniew K Wxzolek. Autosomal Dominant Cerebellar Ataxia Type 1: A review of the phenotypic and genotypic characteristics. Orphanet J Rare Dis. 2011; 6:33. Stewart, Michael W; Vavra, Michael W; Whaley, Nathaniel R. Fundus Findings in a Patient with [alpha]-methylacyl-coa Racemase Deficiency. Retinal Cases & Brief Reports 23 Nov Rubin Devin I and Whaley Nathaniel R. Lower Tibial than Peroneal Compound Muscle Action Potential Amplitude in Neuromuscular Diseases. J Clin Neurophys 2010;27(5): Nathaniel R. Whaley, Devon I. Rubin. Myokymic discharges in amyotrophic lateral sclerosis (ALS): A rare electrophysiologic finding? Muscle & Nerve 2010; 41(1): Whaley NR, Putzke JD, Baba Y, Uitti RJ, Wszolek ZK. Essential tremor: phenotypic expression in a clinical cohort. Parkinsonism and Related Disorders 2007; 13(6): Whaley NR, Uitti RJ, Dickson DW, Farrer MJ, Wszolek ZK. Clinical and pathological features of families with LRRK2-associated Parkinson s disease. J Neural Transm 2006 (Suppl);70; Putzke John D, Whaley NR, Baba Yasuhiko, Wszolek Zbigniew K, and Uitti Ryan. Essential tremor: Predictors of disease progression in a clinical cohort. JNNP 2006;77: /23/2018 4

5 Baba Y, Markopoulou K, Putzke JD, Whaley NR, Farrer MJ, Wszolek ZK, Uitti RJ. Phenotypic commonalities in familial and sporadic Parkinson disease. Arch Neurol 2006;63: Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Progressive supranuclear palsy: phenotypic sex differences in a clinical cohort. Mov Disord 2005;21(5): Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Gender and the Parkinson s disease phenotype. J Neurol 2005;252: Uitti RJ, Baba Y, Whaley NR, Wszolek ZK, Putzke JD. Parkinson disease: handedness predicts asymmetry. Neurology 2005;64: BOOK CHAPTERS Whaley NR and Uitti RJ. Inherited Ataxias, In: Schapira AHV ed. Neurology and Clinical Neuroscience. Philadelphia: Mosby Elsevier; 2007;pp N.R. Whaley and Ryan J. Uitti. Clumsy Gait and Leg Pain. In: Reich S, editor, Movement Disorders: 100 Instructive Cases. Boca Raton: Taylor & Francis Group; 2008; pp CLINICAL RESEARCH EXPERIENCE 1. A Double-Blind, Multi-Center, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of XXX (Ferric Carboxymaltose) in the Treatment of Restless Legs Syndrome (RLS). Sub-Investigator Prospective Randomized 12-Week Controlled Study of Visual Field Change in Subjects With Partial Seizures Receiving Pregabalin or Placebo. Sub-Investigator Novartis OMB157G2301 A Phase III Randomized, Double-Blind, Double-Dummy, Parallel Group study comparing the efficacy and safety of Ofatumumab administered subcutaneously versus Teriflunomide administered orally in patients with relapsing forms of Multiple Sclerosis An Escalating Multiple Dose Study of ABT-555 in Subjects with Relapsing Forms of Multiple Sclerosis. Abbvie. Sub-Investigator A Multicenter, Open-Label Safety and Efficacy Study of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients with Walking Impairment. Protocol ADS-AMT- MS303. Adamas Pharmaceuticals. Principle Investigator A 3-Arm, Multicenter, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients with Walking Impairment. Protocol ADS-AMT-MS301. Adamas Pharmaceuticals. Principal Investigator /3/2018 5

6 7. A Phase 3 Study in Subjects with Relapsing Remitting Multiple Sclerosis to Evaluate the Tolerability of ALKS 8700 and Dimethyl Fumarate. Protocol: ALKS8700-A302. Alkermes. Principal Investigator. April Present. 11/27/2018 6